Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 15 Mar 2024 18:30 CET |
UMICORE | Umicore - Transparantieverklaringen van BlackRock, Inc. | 55201020 Specialty Chemicals | New |
| 15 Mar 2024 18:30 CET |
UMICORE | Umicore - Transparency notifications by BlackRock, Inc. | 55201020 Specialty Chemicals | New |
| 15 Mar 2024 18:30 CET |
UMICORE | Umicore - Déclarations de transparence par BlackRock, Inc. | 55201020 Specialty Chemicals | New |
| 15 Mar 2024 17:45 CET |
WAREHOUSES ESTATES BELGIUM - W.E.B. | WEB SA - RESULTATS ANNUELS EXERCICE 2023 | 35102030 Office REITs | Other subject |
| 15 Mar 2024 17:45 CET |
WAREHOUSES ESTATES BELGIUM - W.E.B. | WEB SA - JAARRESULTATEN BOEKJAAR 2023 | 35102030 Office REITs | Other subject |
| 15 Mar 2024 17:06 CET |
EURONAV | Verzoek Fourworld ook in België afgewezen – Biedingen zijn volgens schema gesloten | 50206030 Marine Transportation | Other subject |
| 15 Mar 2024 17:06 CET |
EURONAV | Fourworld request also denied in Belgium – Offers have closed as scheduled | 50206030 Marine Transportation | Other subject |
| 15 Mar 2024 07:30 CET |
ONWARD MEDICAL | ONWARD® Medical Reaffirms Guidance, Shares 2024 Strategic Priorities, and Releases Unaudited Q4 Financial Highlights | 20101025 Health Services | - |
| 15 Mar 2024 07:30 CET |
ONWARD MEDICAL | ONWARD renforce son management avec des nominations clés dans le domaine clinique et réglementaire et en marketing | 20101025 Health Services | - |
| 15 Mar 2024 07:30 CET |
ONWARD MEDICAL | ONWARD verstärkt Führungsteam auf Schlüsselpositionen in den Bereichen Clinical & Regulatory sowie Marketing | 20101025 Health Services | - |
| 15 Mar 2024 07:30 CET |
ONWARD MEDICAL | ONWARD versterkt management met kernfuncties in Klinische & Regelgevende en Marketingafdelingen | 20101025 Health Services | - |
| 14 Mar 2024 18:30 CET |
FAGRON | Fagron publiceert jaarverslag 2023 | 20102010 Medical Equipment | Other subject |
| 14 Mar 2024 18:30 CET |
FAGRON | Fagron publishes annual report 2023 | 20102010 Medical Equipment | Other subject |
| 14 Mar 2024 18:28 CET |
GBL | GBL - Resultaten op 31 december 2023 | 30202000 Diversified Financial Services | Income |
| 14 Mar 2024 18:27 CET |
GBL | GBL - Résultats au 31 décembre 2023 | 30202000 Diversified Financial Services | Income |
| 14 Mar 2024 18:26 CET |
GBL | GBL - Results as of December 31, 2023 | 30202000 Diversified Financial Services | Income |
| 14 Mar 2024 17:45 CET |
SOLVAC NOM(RETAIL) | Dividend per aandeel stijgt met 4,1 % in 2023 vergeleken met 2022 | 55201000 Chemicals: Diversified | Change in Capital |
| 14 Mar 2024 17:45 CET |
SOLVAC NOM(RETAIL) | Increase of 4.1 % of the dividend per share in 2023 compared to 2022 | 55201000 Chemicals: Diversified | Change in Capital |
| 14 Mar 2024 17:45 CET |
SOLVAC NOM(RETAIL) | Dividende par action en augmentation de 4,1 % en 2023 par rapport à 2022 | 55201000 Chemicals: Diversified | Change in Capital |
| 14 Mar 2024 11:22 CET |
WAREHOUSES ESTATES BELGIUM - W.E.B. | WEB SA - MODIFICATION AGENDA FINANCIER EXERCICE 2023 | 35102030 Office REITs | Other subject |
| 14 Mar 2024 08:15 CET |
AGEAS | ageas SA/NV organiseert een Buitengewone Algemene Vergadering van Aandeelhouders | 30301010 Life Insurance | Other financial transaction |
| 14 Mar 2024 08:15 CET |
AGEAS | ageas SA/NV organises Extraordinary General Meeting of Shareholders | 30301010 Life Insurance | Other financial transaction |
| 14 Mar 2024 08:15 CET |
AGEAS | ageas SA/NV organise une Assemblée Générale Extraordinaire des Actionnaires | 30301010 Life Insurance | Other financial transaction |
| 14 Mar 2024 08:05 CET |
EURONAV | Verzoek Fourworld afgewezen – Biedingen zullen sluiten volgens schema | 50206030 Marine Transportation | Other subject |
| 14 Mar 2024 08:03 CET |
EURONAV | Fourworld request denied – Offers will close as scheduled | 50206030 Marine Transportation | Other subject |
| 14 Mar 2024 07:00 CET |
HYLORIS | Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives | 20103010 Biotechnology | Income |
| 14 Mar 2024 07:00 CET |
ION BEAM APPLICATIONS | PanTera signs a second agreement for the supply of actinium-225 | 20102010 Medical Equipment | News contracts |
| 14 Mar 2024 07:00 CET |
HYLORIS | Hyloris Reports Full Year Results for 2023 & Provides Business Outlook | 20103010 Biotechnology | Income |
| 14 Mar 2024 06:59 CET |
HYLORIS | Communication at the request of the FSMA on the transactions with Qliniq | 20103010 Biotechnology | Other financial transaction |
| 14 Mar 2024 06:59 CET |
HYLORIS | Communiqué à la requête de la FSMA sur les transactions avec QliniQ | 20103010 Biotechnology | Other financial transaction |
| 13 Mar 2024 19:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Press release – Persbericht – Communiqué de presse: a change in the composition of the Supervisory Board | 35102030 Office REITs | Corporate life |
| 13 Mar 2024 19:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses SA: Communiqué de presse – Persbericht - Press release: a change in the composition of the Supervisory Board | 35102030 Office REITs | Corporate life |
| 13 Mar 2024 19:00 CET |
OXURION | Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC | 20103010 Biotechnology | - |
| 13 Mar 2024 19:00 CET |
INTERVEST OFF-WARE | Intervest Offices & Warehouses NV: Persbericht – Communiqué de presse – Press release: a change in the composition of the Supervisory Board | 35102030 Office REITs | Corporate life |
| 13 Mar 2024 18:30 CET |
EVS BROADC.EQUIPM. | PUBLICATION RELATIVE À UNE NOTIFICATION DE TRANSPARENCE | 15101010 Telecommunications Equipment | Corporate life |
| 13 Mar 2024 18:30 CET |
EVS BROADC.EQUIPM. | PUBLICATION OF A TRANSPARENCY NOTIFICATION | 15101010 Telecommunications Equipment | Corporate life |
| 13 Mar 2024 12:15 CET |
AGEAS | Ageas SA/NV confirms improved possible offer for Direct Line Insurance Group Plc (Nederlandse versie volgt later) | 30301010 Life Insurance | - |
| 13 Mar 2024 12:15 CET |
AGEAS | Ageas SA/NV confirms improved possible offer for Direct Line Insurance Group Plc | 30301010 Life Insurance | - |
| 13 Mar 2024 12:15 CET |
AGEAS | Ageas SA/NV confirms improved possible offer for Direct Line Insurance Group Plc (La version française suivra) | 30301010 Life Insurance | - |
| 13 Mar 2024 10:04 CET |
AGFA-GEVAERT | Correction: The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines - regulated information | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 10:04 CET |
AGFA-GEVAERT | Correction: De Agfa-Gevaert Groep in 2023: EBITDA van de Groep 52% hoger, onder impuls van de groeimotoren - gereglementeerde informatie | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 09:18 CET |
SHURGARD | 20240304 Shurgard finalizes its transaction in German | 35101010 Real Estate Holding and Development | Mergers, Acquiqitions, Transferts |
| 13 Mar 2024 08:20 CET |
TITAN CEMENT | Résultats annuels 2023 | 50101030 Cement | Commercial results |
| 13 Mar 2024 08:19 CET |
TITAN CEMENT | Full Year Results 2023 | 50101030 Cement | Commercial results |
| 13 Mar 2024 07:45 CET |
AGFA-GEVAERT | The Agfa-Gevaert Group in 2023: Group EBITDA increases by 52%, powered by its growth engines - regulated information | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 07:45 CET |
AGFA-GEVAERT | Jeroen Spruyt appointed as President of Agfa’s Radiology Solutions division | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 07:45 CET |
AGFA-GEVAERT | De Agfa-Gevaert Groep in 2023: EBITDA van de Groep 52% hoger, onder impuls van de groeimotoren - gereglementeerde informatie | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 07:45 CET |
AGFA-GEVAERT | Jeroen Spruyt benoemd tot President van Agfa’s divisie Radiology Solutions | 50202025 Electronic Equipment: Gauges and Meters | Other subject |
| 13 Mar 2024 07:00 CET |
SOLVAY | Solvay 2023 vierde kwartaal en jaarresultaten | 55201000 Chemicals: Diversified | Corporate life |
| 13 Mar 2024 07:00 CET |
SOLVAY | Solvay fourth quarter and full-year 2023 results | 55201000 Chemicals: Diversified | Corporate life |